AM-PHARMA
Timeline
26 events since 2010Board
Filings
Financial
Establishments
Address
201020122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 30 days before the deadline
2025
Weakest financial year net -€38,840 The net result drops to -€38,840, the lowest from 2011 to 2025.
Annual accounts 2024 filed PDFabbreviated format · 21 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0829559341
2024
Equity above €500,000 equity €532,233 ▲11% After 10 profitable years in a row, equity reaches €532,233.
Annual accounts 2023 filed PDFabbreviated format · 22 days late
2023
Annual accounts 2022 filed PDFabbreviated format · 27 days before the deadline
Purpose change · Amendment of the articles · Legal-form change · Resignations & appointments“Het administratief en commercieel beheer van één of meer apotheken uitgebaat onder het wetenschappelijk…” (deed in Dutch) · Board composition: ADRIAEN Katrien (director (not named in the articles)) · Registered office clause: Dronckaertstraat 618, 8930 Menen (Lauwe)3 points ▸
- 1,500 shares
- Board composition, ADRIAEN Katrien (director (not named in the articles))
- Registered office clause, Dronckaertstraat 618, 8930 Menen (Lauwe)
- The deed holds 3 more points.
2022
Annual accounts 2021 filed PDFabbreviated format · 31 days late
2021
Annual accounts 2020 filed PDFabbreviated format · 45 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 22 days before the deadline
2019
Highest result from 2011 to 2025 net €59,387 ▲65.1% The operating result of €111,661 and the net result of €59,387 are both a record.
Annual accounts 2018 filed PDFabbreviated format · 23 days before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 31 days late
2017
Equity above €200,000 equity €215,895 ▲20% After 3 profitable years in a row, equity reaches €215,895.
Annual accounts 2016 filed PDFabbreviated format · 31 days before the deadline
2016
Equity above €150,000 equity €179,950 ▲21.9% After 2 profitable years in a row, equity reaches €179,950.
Annual accounts 2015 filed PDFabbreviated format · 73 days late
2015
Back to profit net €37,161 The net result is €37,161, after one loss-making year.
Annual accounts 2014 filed PDFabbreviated format · 39 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 45 days before the deadline
2013
Back to profit net €55 The net result is €55, after 2 loss-making years.
Annual accounts 2012 filed PDFabbreviated format · 44 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 50 days before the deadline
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank